🔎 Trials Near Me

Nyumbani › Kushindwa kwa Moyo › Washington

Majaribio ya kliniki ya Kushindwa kwa Moyo katika jimbo la Washington

Masomo 26 ya Kushindwa kwa Moyo yanatafuta washiriki katika vituo vya jimbo la Washington.

Miji katika jimbo la Washington

Maandishi rasmi ya utafiti (Kiingereza)

ELEVATE-HFpEF Clinical Study

  • Saint Joseph Medical Center (Tacoma WA), Tacoma
Inaajiri
Umri 40 na zaidi · Jinsia zote · Imesasishwa 2 Okt 2026 · NCT06678841

A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure

  • Virginia Mason Medical Center, Seattle
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 1 Okt 2026 · NCT06424288

A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF

  • Research Site, Redmond
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 28 Sep 2026 · NCT07761117

Study With Omecamtiv Mecarbil (CK-1827452) to Treat Chronic Heart Failure With Severely Reduced Ejection Fraction

  • Providence Advanced Heart Disease and Transplant, Spokane
InaajiriHatua 3
Umri 18 hadi 85 · Jinsia zote · Imesasishwa 24 Sep 2026 · NCT06736574

Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity

  • Pulse Heart Institute, Puyallup
InaajiriHatua 3
Umri 18 hadi 99 · Jinsia zote · Imesasishwa 16 Sep 2026 · NCT07037459

Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin

  • Research Site, Puyallup
  • Research Site, Redmond
  • Research Site, Renton
InaajiriHatua 3
Umri 40 na zaidi · Jinsia zote · Imesasishwa 15 Sep 2026 · NCT06677060

A Study to Determine the Efficacy and Safety of Finerenone on Morbidity and Mortality Among Hospitalized Heart Failure Patients

  • Spokane, WA Investigative Site 10123, Spokane
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 10 Sep 2026 · NCT06008197

A Study of EDG-15400 in Adults With Heart Failure With Preserved Ejection Fraction (EQUINOX-HFpEF)

  • Local Institution - 132, Seattle
InaajiriHatua 2
Umri 30 hadi 84 · Jinsia zote · Imesasishwa 31 Ago 2026 · NCT07795814

Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)

  • Seattle Children's Hospital-Cardiology/Fetal Therapy ( Site 0019), Seattle
InaajiriHatua 2/3
29 Days – 17 Years · Jinsia zote · Imesasishwa 28 Ago 2026 · NCT05714085

AMBER-HFpEF: Assessment of CK-4021586 in a Multi-Center, Blinded Evaluation of Safety and Tolerability Results in HFpEF

  • Swedish Heart & Vascular Institute, Advanced Cardiac Support Program, Seattle
InaajiriHatua 2
Umri 40 hadi 85 · Jinsia zote · Imesasishwa 27 Ago 2026 · NCT06793371

Product Performance Report: Evaluate Long-term Reliability & Performance of Medtronic Marketed Cardiac Therapy Products

  • Olympia
InaajiriUtafiti wa uchunguzi
Umri wote · Jinsia zote · Imesasishwa 20 Ago 2026 · NCT00271180

LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2

  • Tenax Investigational Site, Seattle
InaajiriHatua 3
Umri 18 hadi 85 · Jinsia zote · Imesasishwa 19 Ago 2026 · NCT07288398

A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity

  • Swedish Medical Center_Seattle, Seattle
  • CHI Franciscan Research Center, Tacoma
InaajiriHatua 3
Umri 18 na zaidi · Jinsia zote · Imesasishwa 18 Ago 2026 · NCT07567001

Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System

  • Seattle Children's Hospital, Seattle
InaajiriHatua 2
Umri 0 hadi 16 · Jinsia zote · Imesasishwa 10 Ago 2026 · NCT06080074

Assessment of CCM in HF With Higher Ejection Fraction

  • Swedish Medical Center, Seattle
  • Peace Health, Vancouver
Inaajiri
Umri 18 na zaidi · Jinsia zote · Imesasishwa 6 Ago 2026 · NCT05064709

PROACTIVE-HF-2 Trial Heart Failure NYHA Class II and III

  • Providence Everett, Everett
Inaajiri
Umri 18 na zaidi · Jinsia zote · Imesasishwa 29 Jun 2026 · NCT05934487

Repurposing Valsartan May Protect Against Pulmonary Hypertension

  • University of Washington Medical Center, Seattle
InaajiriHatua 2
Umri 18 hadi 80 · Jinsia zote · Imesasishwa 4 Mei 2026 · NCT06053580

CCM OPEN HF Registry

  • PeaceHealth Southwest Medical Center, Vancouver
InaajiriUtafiti wa uchunguzi
Umri 18 na zaidi · Jinsia zote · Imesasishwa 23 Apr 2026 · NCT07112924

Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease

  • University of Washington, Seattle
  • Providence Sacred Heart Medical Center, Spokane
InaajiriHatua 3
Umri 18 hadi 75 · Jinsia zote · Imesasishwa 24 Mac 2026 · NCT06217302

XVIVO Heart Box (XHB) With Supplemented XVIVO Heart Solution (SXHS) Continued Access Protocol (CAP)

  • University of Washington Medical Center, Seattle
Inaajiri
Umri 18 na zaidi · Jinsia zote · Imesasishwa 18 Mac 2026 · NCT06895070

Proof-of-concept of a Behavioral Intervention to Improve the Cardiovascular Health of People Living With HIV

  • University of Washington, Seattle
Inaajiri
Umri 40 na zaidi · Jinsia zote · Imesasishwa 16 Mac 2026 · NCT07105007

Left vs Left Randomized Clinical Trial

  • University of Washington, Seattle
Inaajiri
Umri 18 na zaidi · Jinsia zote · Imesasishwa 2 Okt 2025 · NCT05650658

Cardiogenic Shock Working Group Registry

  • University of Washington Medical Center, Seattle
InaajiriUtafiti wa uchunguzi
Umri 18 na zaidi · Jinsia zote · Imesasishwa 6 Jun 2025 · NCT04682483

Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction

  • University of Washington Medicine, Seattle
InaajiriHatua 1/2
Umri 18 hadi 80 · Jinsia zote · Imesasishwa 26 Mac 2024 · NCT04703842

Study of the Clinical Impact of Surgical Correction of Tricuspid Insufficiency in Implantable LVAD Patients

  • University of Washington Medical Center, Seattle
Inaajiri
Umri 18 na zaidi · Jinsia zote · Imesasishwa 23 Feb 2021 · NCT02537769

Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.